Status:
COMPLETED
Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport
Lead Sponsor:
Children's Mercy Hospital Kansas City
Conditions:
Anemia, Sickle Cell
Eligibility:
All Genders
8-18 years
Brief Summary
This study is being done to see what impact having a Lifeport device has on quality of life for children with sickle cell who are getting chronic transfusions, from the child's perspective.
Detailed Description
There is a paucity of research that focuses specifically on quality of life (QoL) among patients with sickle cell. This study aims to explore the QoL of children who are receiving chronic transfusion ...
Eligibility Criteria
Inclusion
- Individuals with a diagnosis of sickle cell disease between the ages of 8 \& 18 years
- currently receiving chronic transfusion therapy via a Lifeport device
- Individuals have been utilizing the Lifeport for at least 6 months and no more than 18 months
- Individuals have received transfusions previously using conventional transfusion therapy (simple or exchange transfusions)
- Individuals have permission of parents (when applicable) and assent
Exclusion
- Individuals who, in the opinion of the study staff, would suffer negative consequence, psychosocial trauma, or undue stress as a result of participation
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
End Date :
December 1 2005
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00246077
Start Date
October 1 2005
End Date
December 1 2005
Last Update
April 11 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Mercy Hospital
Kansas City, Missouri, United States, 64108